[1]
Albareda, N., Zeichner, J. and Rosenberg, N. 2017. A Randomized Vehicle-Controlled Trial to Assess the Efficacy, Safety, and Tolerability of Ozenoxacin 1% Cream in 412 Patients 2 Months and Older with Impetigo. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s103. DOI:https://doi.org/10.25251/skin.1.supp.102.